Necrotizing encephalopathy following intraventricular instillation of methotrexate.
D000293:Adolescent; D001921:Brain / Q000473:pathology; D001927:Brain Diseases / Q000139:chemically induced* / Q000473:pathology; D001932:Brain Neoplasms / Q000188:drug therapy*; D002330:Carmustine / Q000627:therapeutic use; D002528:Cerebellar Neoplasms / Q000188:drug therapy; D002551:Cerebral Ventricle Neoplasms / Q000188:drug therapy; D002552:Cerebral Ventricles / Q000187:drug effects; D002648:Child; D005260:Female; D005910:Glioma / Q000188:drug therapy*; D006801:Humans; D007278:Injections, Spinal; D007938:Leukemia / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008527:Medulloblastoma / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged
D002330:Carmustine; D008727:Methotrexate